Примери за използване на The pharmacokinetic на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
has no clinically relevant effects on the pharmacokinetic of fexofenadine.
The pharmacokinetic enhancing effect of pharmacokinetic enhancer other than ritonavir on darunavir was evaluated in a Phase I study in healthy subjects that were administered darunavir 800 mg with ritonavir at 100 mg
The pharmacokinetic enhancing effect of cobicistat on darunavir was evaluated in a Phase I study in healthy subjects that were administered darunavir 800 mg with either cobicistat at 150 mg
The pharmacokinetic enhancing effect of cobicistat on darunavir was evaluated in a phase 1 clinical study GS-US-216-0115 in 31 healthy subjects that were administered darunavir 800 mg in combination with cobicistat 150 mg
however, in the pharmacokinetic and clinical studies the systemic exposure,
without concomitant telmisartan medication, no clinical consequences of the pharmacokinetic medicinal product-medicinal product interaction were seen.
The pharmacokinetic(PK) parameters in the anti-TNF inadequate responder population,
However, the pharmacokinetic and pharmacodynamic properties of soluble insulin aspart have been studied in children(6 to 12 years)
Population PK models developed from studies in patients with Parkinson's disease indicate that the pharmacokinetic and pharmacodynamics effects of safinamide were not dependent on age,
While no evidence was available to indicate that the pharmacokinetic and residue depletion behaviour following administration of the different nitroxinil containing products would be identical to that seen in the available study,
Results from two clinical studies investigating the pharmacokinetic(PK) profile of candesartan in patients with impaired hepatic function
altered toxicity profile in the presence of nivolumab antibodies based on the pharmacokinetic and exposure-response analyses for both monotherapy and combination.
The pharmacokinetic(PK) parameters in the anti-TNF inadequate responder population,
The pharmacokinetic profiles indicated dose proportionality.
The pharmacokinetic profiles indicated dose proportionality.
The pharmacokinetic effect was not investigated.
The pharmacokinetic profile of ciclosporin was not significantly altered.
The pharmacokinetic parameters confirm the effective dose of tilmicosin.
The pharmacokinetic parameters in the second study were comparable.